A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis

Clinical trial NCT07298044 · RECRUITING

Trial details

NCT number: NCT07298044
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy

Start date: 2026-02-13
Primary completion: 2027-07-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.